Screening methods for cervical cancer for the general population: joint recommendations of the American cancer society, the American society for colposcopy and cervical pathology, and the American society for clinical pathology
|
Population |
Recommended Screening Method |
Comment |
|
Women younger than 21 years |
No screening | |
|
Women aged 21-29 years |
Cytology alone every 3 years | |
|
Women aged 30-65 years |
Human papillomavirus and cytology cotesting (preferred) every 5 years Cytology alone (acceptable) every 3 years |
Screening by HPV testing alone is not recommended* |
|
Women older than 65 years |
No screening is necessary after adequate negative prior screening results |
Women with history of CIN 2, CIN 3, or adenocarcinoma in situ should continue routine age-based screening for a total of 20 years after spontaneous regression or appropriate management of CIN 2, CIN 3, or adenocarcinoma in situ |
|
Women who underwent total hysterectomy |
No screening is necessary |
Applies to women without a cervix and without a history CIN 2, CIN 3, adenocarcinoma in situ, or cancer in the past 20 years |
|
Women vaccinated against HPV |
Follow age-specific recommendations (same as unvaccinated women) |